Status:
COMPLETED
Study of the Reversibility of Vigilance Dysfunction at 6 Months of Continuous Positive Airways Pressure (CPAP) in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS)
Lead Sponsor:
Poitiers University Hospital
Conditions:
Vigilance Dysfunction
Eligibility:
All Genders
20-69 years
Phase:
NA
Brief Summary
It is a monocentric prospective pilot study in Poitiers University Hospital, specifically analyzing the vigilance disorders in the Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) and their reversibi...
Eligibility Criteria
Inclusion
- Patients aged 20-70 years
- Memory disorders without memory problems in episodic memory
- Presence of polysomnography of a obstructive sleep apnea/hypopnea syndrome (OSAHS) requiring Continuous positive airways pressure
- Moderate OSAHS (Apnea Hypopnea Index ≥ 15 / hour with arousals ≥ 10)
- Severe OSAHS (Apnea Hypopnea Index ≥ 30 / h)
Exclusion
- Age \<20 years or ≥ 70 years
- Neurodegenerative disease (Alzheimer's disease, Parkinson's disease)
- Dysthyroidism
- Severe depression, schizophrenia, bipolar disorder
- Treatment with an effect on cognition: hypnotics, sedative
- Chronic Obstructive Pulmonary Disease
- Chronic alcoholism, other addictions
- Contraindications to Magnetic Resonance Imaging
- Refusal of equipment
Key Trial Info
Start Date :
November 17 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 9 2021
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT03344263
Start Date
November 17 2017
End Date
February 9 2021
Last Update
November 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
service de neurologie CHU DE POITIERS
Poitiers, France, 86000